106 results on '"Engert, Andreas"'
Search Results
2. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
3. Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
4. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis
5. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
6. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma
7. Interim PET for prognosis in adults with Hodgkin lymphoma: a prognostic factor exemplar review
8. Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)
9. Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia
10. Low dose cytarabine monotherapy for myelodysplastic syndromes
11. High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data
12. Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes
13. Antibiotics for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation
14. Idiotype vaccination for Non-Hodgkin lymphoma
15. Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers
16. Low dose cytarabine monotherapy for acute myeloid leukaemia
17. Hypomethylating agents for patients with myelodysplastic syndrome
18. Hypomethylating agents for adult patients with acute myeloid leukaemia
19. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy
20. Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (APL))
21. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma
22. Mindfulness-based stress reduction for women diagnosed with breast cancer
23. Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma
24. Aerobic physical exercise for adult patients with haematological malignancies
25. The role of additional radiotherapy for primary central nervous system lymphoma
26. Meditation for adult patients with haematological malignancies
27. Yoga in addition to standard care for patients with haematological malignancies
28. High-dose therapy with autologous stem cell transplantation for patients with chronic lymphocytic leukaemia
29. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple myeloma patients
30. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
31. Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients
32. Erythropoietin or darbepoetin for patients with cancer
33. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
34. Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia
35. Yoga for haematological malignancies
36. First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
37. Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia
38. Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation
39. Thrombopoietin mimetics for patients with myelodysplastic syndromes
40. Alemtuzumab for patients with chronic lymphocytic leukaemia
41. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults
42. Low dose cytarabine monotherapy for acute myeloid leukaemia
43. High-dose therapy with autologous stem cell transplantation for patients with chronic lymphocytic leukaemia
44. Hypomethylating agents for adult patients with acute myeloid leukaemia
45. Low dose cytarabine monotherapy for myelodysplastic syndromes
46. High-dose chemotherapy followed by autologous stem cell transplantation for refractory/relapsed Hodgkin lymphoma patients
47. Hypomethylating agents for patients with myelodysplastic syndrome
48. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
49. Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers
50. Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.